00867 康哲藥業
按盘价 
13.720 +0.760 (+5.864%) 盈利能力分析
| 2025/12 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| 资产回报率 (%) | 7.995% | 9.055% | 13.532% | 19.421% | 21.168% |
| 股东资金回报率 (%) | 8.834% | 10.177% | 15.948% | 23.839% | 25.371% |
| 资本运用回报率 (%) | 8.398% | 9.798% | 15.310% | 21.907% | 21.982% |
边际利润分析
| 2025/12 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| 毛利率 (%) | 71.499% | 72.596% | 76.238% | 76.892% | 74.928% |
| 未计利息、税项、折旧及摊销前利润率 (%) | 25.154% | 24.642% | 34.009% | 42.278% | 42.550% |
| 税前边际利润率 (%) | 25.609% | 26.915% | 35.863% | 41.122% | 41.460% |
| 纯利率 (%) | 18.131% | 21.687% | 29.962% | 35.616% | 36.192% |
变现能力分析
| 2025/12 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| 流动比率 (X) | 6.329 X | 5.742 X | 4.293 X | 3.069 X | 3.546 X |
| 速动比率 (X) | 5.782 X | 5.235 X | 3.981 X | 2.903 X | 3.319 X |
财务杠杆分析
| 2025/12 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| 总负债 / 总资产比率 (%) | 8.626% | 9.113% | 12.264% | 16.991% | 18.730% |
| 总债项 / 总资产比率 (%) | 3.594% | 4.769% | 7.342% | 10.210% | 10.832% |
| 净债项 / 总资产比率 (%) | -10.476% | -15.768% | -16.972% | -14.441% | -10.586% |
| 总债项 / 股东资金比率 (%) | 3.967% | 5.277% | 8.387% | 12.425% | 13.427% |
| 长期债项 / 股东资金比率 (%) | 0.125% | 0.077% | 0.107% | 0.092% | 4.639% |
| 净债项 / 股东资金比率 (%) | -11.562% | -17.446% | -19.390% | -17.573% | -13.122% |
| 净现金 / (债项) ($) | 20.11亿 | 28.46亿 | 30.09亿 | 25.64亿 | 16.73亿 |
| 每股净现金 / (债项) ($) | 0.824 | 1.167 | 1.227 | 1.046 | 0.681 |
| 总债项 / 资本运用比率 (%) | 3.892% | 5.207% | 8.301% | 12.185% | 12.474% |
| 利息盈利率 (X) | 104.614 X | 53.067 X | 63.134 X | 77.658 X | 123.271 X |
营运效率分析
| 2025/12 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| 存货周转率日数 (日) | 122.583日 | 125.344日 | 106.852日 | 81.976日 | 74.545日 |
| 应收贸易帐周转率日数 (日) | 71.907日 | 67.170日 | 69.219日 | 71.018日 | 73.179日 |
| 应付贸易帐周转率日数 (日) | 5.534日 | 6.942日 | 7.280日 | 6.460日 | 6.145日 |
| 备注： | 实时报价更新时间为18/03/2026 17:59 |
| 港股实时基本市场行情由香港交易所提供; 香港交易所指定免费发放实时基本市场行情的网站。 | |
| 股东应占溢利/(亏损) (千) | RMB 1,488,892 |
| 增长率 | -8.081% |
| 每股盈利/(亏损) | RMB 0.615 |
| 每股账面资产净值 (¥) | RMB 7.131 |